MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
LONN.SW stock logo

LONN.SW

Lonza Group AG

$479.2
5.2
 (1.1%)
[ms_data_label text=’Delayed data’]
Exchange:  SIX
Market Cap:  33.469B
Shares Outstanding:  74.256M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Diagnostics & Research
   
CEO:  Wolfgang Wienand
Full Time Employees:  17995
Address: 
Muenchensteinerstrasse 38
Basel
4002
CH
Website:  https://www.lonza.com
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue6,717,0006,574,0006,531,000
Gross Profit1,948,0002,160,0002,309,000
EBITDA1,532,0001,542,0001,310,000
Operating Income880,000964,0001,382,000
Net Income654,000636,000949,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets16,848,00019,733,00018,967,000
Total Liabilities7,336,00010,345,0009,780,000
Total Stockholders Equity9,452,0009,328,0009,134,000
Total Debt3,132,0005,120,0004,185,000
Cash and Cash Equivalents1,468,0001,111,000719,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow1,385,0001,274,0001,169,000
Capital Expenditure-1,648,000-1,417,000-1,373,000
Free Cash Flow-263,000-143,000-204,000
Net Income654,000636,000949,000
Net Change in Cash129,000-357,000-392,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)11,093,668.380Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)11,682,350.251Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)11,393,750Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)2,792,472.831Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)2,940,654.485Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)2,868,008.690Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)2,410,535.417Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)2,578,185.017Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)2,495,995.089Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)1,459,443.901Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,536,888.813Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,498,921.581Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)35.570Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)36.740Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)34.350Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)8Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)5Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
5.81
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
41.95
?Enterprise Value
 (TTM)
: 
41.419B  ?EV/FCF
 (TTM)
: 
-195.37
?Dividend Yield
 (TTM)
: 
0.01  ?Payout Ratio
 (TTM)
: 
0.31
?ROE
 (TTM)
: 
0.1  ?ROIC
 (TTM)
: 
0.07
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.46
?P/B
 (TTM)
: 
4.18  ?Current Ratio
 (TTM)
: 
2.24

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
21.76Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate LONN Intrinsic Value

Common questions about LONN.SW valuation

Is Lonza Group AG (LONN.SW) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Lonza Group AG (LONN.SW) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is LONN.SW a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether LONN.SW trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is LONN.SW’s P/E ratio?

You can see LONN.SW’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for LONN.SW?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is LONN.SW a good long-term investment?

Whether LONN.SW fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

LONN.SW

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

1.1
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low: 454.6   Year High: 605.2
Price Avg 50: 504.33   Price Avg 200: 535.61
Volume: 151214   Average Volume: 172501

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for LONN

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read